在心房的微RNAs:机制,血管的影响,和治疗潜力
Emmanouil P Vardas1,2, Panagiotis Theofilis1, Evangelos Oikonomou3
11st Cardiology Department, General Hospital of Athens "Hippokration", University of Athens Medical School, 11528 Athens, Greece.
Biomedicines
|April 27, 2024
概括
微RNAs (miRNAs) 通过影响纤维化,炎症和氧化应激显著促进心房动 (AFib) 病理生理学. 针对特定的miRNA显示出新型AFib诊断和个性化治疗策略的前景.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 心房动 (AFib) 是一种普遍存在的心律失常症,对全球健康的影响越来越大,特别是在老年人群中.
- AFib病理生理学涉及复杂的机制,包括纤维化,炎症和氧化应激.
- 微RNAs (miRNAs) 是关键的调节者,与这些病理途径有关.
研究的目的:
- 审查miRNAs在心房动中的多方面的作用.
- 阐明将miRNA与AFib病理生理学联系起来的分子机制.
- 探索miRNAs在AFib管理中的诊断和治疗潜力.
主要方法:
- 关于miRNAs和心房的当前研究的文献综述.
- 分析涉及miRNAs,纤维化,炎症和氧化应激的分子通路.
- 对基于miRNA的诊断标记物和治疗干预措施的证据的审查.
主要成果:
- miRNAs显著调节纤维化,炎症和氧化应激路径,这些路径对AFib发展至关重要.
- 特定的miRNAs (例如,miR-1,miR-328,miR-27b,miR-223-3p) 被确定为AFib治疗的潜在标.
- miRNA表达特征可以作为AFib的诊断生物标志物.
结论:
- miRNAs是心房的复杂病理生理学的组成部分.
- 针对特定的miRNAs为开发新型诊断工具和针对AFib的个性化治疗提供了一个有希望的途径.
- 了解miRNA-遗传倾向相互作用是推动AFib精准医学的关键.
相关概念视频
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
980
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
980
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
832
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
832
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
687
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
687
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
496
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
496